Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review

Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review

(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when confronte...

Full description

Saved in:
Bibliographic Details
Published in:Economies Vol. 11; no. 1; p. 25
Main Authors: Marrone, Patrícia Véras, Mathias, Fabio Rampazzo, Bernardo, Wanderley Marques, Orlandini, Marina Feliciano, Serafim, Maria Carolina Andrade, Scoton, Maria Lídia Rebello Pinho Dias, Lopes, Juliano Marçal, Pereira, Sérgio Luiz, Dias, Eduardo Mario
Format: Journal Article
Language:English
Published: Basel MDPI AG 01-01-2023
Subjects:
COVID-19
Decision making
healthcare
local production
Nationalization
pharmaceutical supply chain
PSC
reshoring
Suppliers
United States > US
China
India
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when confronted by a major global health and humanitarian crisis, many countries have taken steps to mitigate the risks of disruption, including, for example, recommending the adoption of a plus one diversification approach, increasing safety stock, and nationalizing the medical supply chains. (2) Objective: To scope findings in the academic literature related to decision criteria to guide national policy decisions for the “Partial Nationalization of Pharmaceutical Supply Chain” (PNPSC) from the viewpoints of the three main stakeholders: industry, payers (government and health insurance), and patients. (3) Methods: These consist of a scoping review of the peer-reviewed literature. (4) Results: A total of 115 studies were included. For local manufacturing decisions, five criteria and 15 sub-criteria were identified. Weighting, decision-making, risk assessment, and forecasting were the main data analysis tools applied; (5) Conclusions: The findings could serve as a baseline for constructing PNPSC frameworks after careful adaptation to the local context.
ISSN:2227-7099
2227-7099
DOI:10.3390/economies11010025